Yanhong Zhou
5PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton
|Nov 05, 2022
AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials.Yanhong Zhou, Yujie Zhao, Greg Cicconetti
|May 19, 2021
The use of local and nonlocal priors in Bayesian test-based monitoring for single-arm phase II clinical trials.Yanhong Zhou, Ruitao Lin, J Jack Lee
|Dec 07, 2020
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies.Ruitao Lin, Yanhong Zhou, Fangrong Yan
|Oct 18, 2019
A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies.Yanhong Zhou, J Jack Lee, Ying Yuan
Pageof 1
Frequent Collaborators
3 joint publications
Ying Yuan
2 joint publications
Ruitao Lin
1 joint publications
J Jack Lee
1 joint publications
Yujie Zhao
1 joint publications
Kevin Kalinsky
1 joint publications
Giampaolo Bianchini
1 joint publications
Erika Hamilton
1 joint publications
Stephanie L Graff
1 joint publications
Kyong Hwa Park
1 joint publications
Rinath Jeselsohn
